Evidence map›Paper›PMID 33126412›Full record

ArticleAntibiotics (Basel, Switzerland)2020

Point-of-Care Testing for Pharyngitis in the Pharmacy.

Sabiha Essack, John Bell, Douglas Burgoyne, Wirat Tongrod, Martin Duerden, Aurelio Sessa, Attila Altiner, Adrian Shephard

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 7 countries.

Sabiha EssackAntimicrobial Research Unit, College of Health Sciences, University of KwaZulu-Natal, Durban 4041, South Africa.ORCID 0000-0003-3357-2761
John BellGraduate School of Health, University of Technology Sydney, Ultimo, NSW 2007, Australia.
Douglas BurgoyneCollege of Pharmacy, University of Utah, Salt Lake City, UT 84112, USA.
Wirat TongrodFaculty of Pharmaceutical Sciences, Huachiew Chalermprakiet University, Samut Prakan 10540, Thailand.
Martin DuerdenSchool of Medicine, Centre for Medical Education, Cardiff University, Cardiff CF14 4XN, UK.
Aurelio SessaItalian College of General Practitioners and Primary Care (SIMG, Società Italiana di Medicina Generale delle Cure Primarie), 50142 Florence, Italy.ORCID 0000-0002-9913-9314
Attila AltinerInstitute of General Practice, Rostock University Medical Center, 18055 Rostock, Germany.
Adrian ShephardReckitt Benckiser Healthcare Ltd., Slough SL1 3UH, UK.ORCID 0000-0002-4020-1486
Cardiff University · GBHuachiew Chalermprakiet University · THReckitt Benckiser (United Kingdom) · GBSocietà Italiana di Medicina Generale · ITUniversity of KwaZulu-Natal · ZAUniversity of Rostock · DEUniversity of Technology Sydney · AUUniversity of Utah · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pharyngitis (also known as sore throat) is a common, predominately viral, self-limiting condition which can be symptomatically managed without antibiotic treatment. Inappropriate antibiotic use for pharyngitis contributes to the development and spread of antibiotic resistance. However, a small proportion of sore throats caused by group A streptococcal (GAS) infection may benefit from the provision of antibiotics. Establishing the cause of infection is therefore an important step in effective antibiotic stewardship. Point-of-care (POC) tests, where results are available within minutes, can distinguish between viral and GAS pharyngitis and can therefore guide treatment in primary healthcare settings such as community pharmacies, which are often the first point of contact with the healthcare system. In this opinion article, the evidence for the use of POC testing in the community pharmacy has been discussed. Evidence suggests that pharmacy POC testing can promote appropriate antibiotic use and reduce the need for general practitioner consultations. Challenges to implementation include cost, training and 'who prescribes', with country and regional differences presenting a particular issue. Despite these challenges, POC testing for pharyngitis has become widely available in pharmacies in some countries and may represent a strategy to contain antibiotic resistance and contribute to antimicrobial stewardship.

Indexed as

antibioticsantimicrobial resistanceantimicrobial stewardshipbacterial infectionspharmacypharyngitispoint-of-care testingstreptococcal infectionsupper-respiratory tract infectionsviral infections

Identifiers

PMID33126412
PMCPMC7693205
OpenAlexW3097040457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.